Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:832-838
Published online before print April 13, 2001, doi: 10.1161/hh0801.089177
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
88/8/832    most recent
hh0801.089177v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichinose, F.
Right arrow Articles by Bloch, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichinose, F.
Right arrow Articles by Bloch, K. D.
Related Collections
Right arrow Oxidant stress
Right arrow Receptor pharmacology
Right arrow Genetically altered mice
Right arrow Pulmonary biology and circulation
(Circulation Research. 2001;88:832.)
© 2001 American Heart Association, Inc.


Integrative Physiology

Attenuation of Hypoxic Pulmonary Vasoconstriction by Endotoxemia Requires 5-Lipoxygenase in Mice

Fumito Ichinose, Warren M. Zapol, Adam Sapirstein, Roman Ullrich, Andrew M. Tager, Kenneth Coggins, Rosemary Jones, Kenneth D. Bloch

From the Department of Anesthesia and Critical Care (F.I., W.M.Z., A.S., R.U., R.J.), the Cardiovascular Research Center (F.I., K.D.B.), and the Center for Immunology and Inflammatory Diseases (A.M.T.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass, and Division of Pulmonary and Critical Care Medicine (K.C.), University of North Carolina, Chapel Hill, NC.

Correspondence to Fumito Ichinose, MD, Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114. E-mail ichinose{at}etherdome.mgh.harvard.edu

Abstract—Sepsis and endotoxemia impair hypoxic pulmonary vasoconstriction (HPV), thereby reducing systemic oxygenation. To assess the role of leukotrienes (LTs) in the attenuation of HPV during endotoxemia, the increase in left lung pulmonary vascular resistance (LPVR) before and during left mainstem bronchus occlusion (LMBO) was measured in mice with and without a deletion of the gene encoding 5-lipoxygenase (5-LO). LMBO increased the LPVR equally in saline-challenged wild-type and 5-LO–deficient mice (96±20% and 94±19%, respectively). Twenty-two hours after challenge with Escherichia coli endotoxin, the ability of LMBO to increase LPVR was markedly impaired in wild-type mice (27±7%; P<0.05) but not in 5-LO–deficient mice (72±9%) or in wild-type mice pretreated with MK886, an inhibitor of 5-LO activity (76±10%). Compared with wild-type mice, endotoxin-induced disruption of lung structures and inflammatory cell influx in the lung were markedly attenuated in 5-LO–deficient mice. Administration of MK571, a selective cysteinyl LT1 receptor antagonist, 1 hour before endotoxin challenge preserved HPV and attenuated pulmonary injury in wild-type mice but did not prevent the endotoxin-induced increase in pulmonary myeloperoxidase activity. Taken together, these findings demonstrate that a 5-LO product, most likely a cysteinyl LT, contributes to the attenuation of HPV and to pulmonary injury after challenge with endotoxin.


Key Words: cysteinyl leukotrienes • pulmonary injury • left mainstem bronchus occlusion




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. A. Frank and M. A. Matthay
Leukotrienes in Acute Lung Injury: A Potential Therapeutic Target?
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 261 - 262.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Caironi, F. Ichinose, R. Liu, R. C. Jones, K. D. Bloch, and W. M. Zapol
5-Lipoxygenase Deficiency Prevents Respiratory Failure during Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 334 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Liu, O. V. Evgenov, and F. Ichinose
NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice
J Appl Physiol, February 1, 2005; 98(2): 748 - 752.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. P. Grichnik and T. A. D'Amico
Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 317 - 334.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Ichinose, R. Hataishi, J. C. Wu, N. Kawai, A. C. T. Rodrigues, C. Mallari, J. M. Post, J. F. Parkinson, M. H. Picard, K. D. Bloch, et al.
A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2524 - H2530.
[Abstract] [Full Text] [PDF]